Breakdown | ||||
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
47.96B | 45.22B | 43.42B | 43.34B | 51.33B | Gross Profit |
16.52B | 16.36B | 16.42B | 16.66B | 24.37B | EBIT |
1.95B | 2.40B | 2.97B | 3.35B | 3.63B | EBITDA |
3.60B | 3.71B | 4.04B | 4.65B | 4.69B | Net Income Common Stockholders |
1.40B | 1.80B | 2.18B | 2.70B | 2.51B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
15.82B | 15.23B | 18.50B | 16.75B | 16.29B | Total Assets |
47.37B | 47.95B | 43.15B | 41.30B | 40.32B | Total Debt |
506.00M | 602.00M | 0.00 | 0.00 | 0.00 | Net Debt |
-15.31B | -13.78B | -18.50B | -16.63B | -16.29B | Total Liabilities |
13.15B | 15.13B | 12.22B | 12.22B | 13.26B | Stockholders Equity |
34.22B | 32.82B | 30.93B | 29.08B | 27.06B |
Cash Flow | Free Cash Flow | |||
1.14B | -2.66B | 1.19B | 1.76B | 4.01B | Operating Cash Flow |
4.53B | 767.00M | 2.81B | 3.33B | 4.74B | Investing Cash Flow |
-3.34B | -3.64B | -1.32B | -1.44B | -870.00M | Financing Cash Flow |
-645.00M | -468.00M | 265.00M | -1.69B | -1.23B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥24.21B | 12.88 | ― | 16.73% | 80.15% | ||
66 Neutral | ¥24.34B | 9.40 | 1.88% | 2.09% | -8.76% | ||
65 Neutral | $8.81B | 14.92 | 4.67% | 6.17% | 3.60% | -2.89% | |
65 Neutral | ¥23.74B | 37.73 | 2.04% | 0.93% | 330.14% | ||
64 Neutral | ¥23.60B | 17.68 | 1.97% | 6.08% | -22.00% | ||
64 Neutral | ¥23.50B | 37.83 | 1.66% | -3.88% | -39.50% | ||
62 Neutral | ¥25.35B | 18.75 | 1.19% | 2.76% | -3.44% |